Terms of Service

Effective Date: May 1, 2026 · Last Updated: May 2, 2026

DRAFT — Subject to legal counsel review prior to finalization.

These Terms of Service ("Terms") govern your access to and use of the NanoSense Medical RAG Intelligence Platform (the "Service") operated by NanoSense ("we," "us," or "our"). By accessing or using the Service, you agree to be bound by these Terms.

1. Definitions

2. Account Registration

To use the Service, you must register a tenant account and provide accurate, complete information. You are responsible for maintaining the confidentiality of your API keys and credentials. You must notify us immediately at security@nanosense.net if you suspect unauthorized use of your account.

3. Permitted Use

The Service is provided for:

The Service provides AI-generated clinical information and is intended as a decision-support tool only. It does not constitute medical advice, diagnosis, or treatment. Healthcare professionals must exercise independent clinical judgment when using outputs from the Service.

4. Prohibited Use

You agree not to:

5. Pricing and Payment

5.1 Subscription Plans

The Service is offered under usage-based subscription plans as described on our Pricing page. Each plan includes a monthly token allocation. We reserve the right to modify pricing with 30 days' advance notice.

5.2 Overage

Usage exceeding your plan's included tokens is billed at the overage rate specified in your plan (currently $0.002 per 1,000 tokens). You may set hard or soft token budget limits via the API to prevent unexpected overages.

5.3 Payment Terms

Subscriptions are billed monthly in advance. Overage charges are billed in arrears. Payment is due within 30 days of invoice. We reserve the right to suspend access for accounts more than 15 days past due.

6. Service Level Agreement

We target 99.9% monthly uptime for the API (excluding scheduled maintenance). Scheduled maintenance windows will be announced at least 72 hours in advance. Enterprise customers with custom SLAs are governed by the terms of their individual agreements. Service credits for downtime exceeding the SLA target are available to Professional and Enterprise customers.

7. Data and Privacy

7.1 Data Ownership

You retain all rights to data you submit to the Service. We do not claim ownership of your queries, patient context, or any data you transmit through the API.

7.2 Data Processing

We process your data solely to deliver the Service. We do not use customer query data to train machine learning models. Our data handling practices are described in our Privacy Policy.

7.3 HIPAA and BAA

Customers who are Covered Entities or Business Associates under HIPAA must execute a Business Associate Agreement before transmitting PHI. Our BAA template is available for review. Without a signed BAA, you must de-identify all data before transmission in accordance with the HIPAA Safe Harbor method.

8. Intellectual Property

The Service, including its software, algorithms, APIs, documentation, and branding, is the intellectual property of NanoSense and is protected by applicable intellectual property laws. These Terms do not grant you any right to use the NanoSense name, logo, or trademarks without our prior written consent.

9. Disclaimers

9.1 No Medical Advice

THE SERVICE IS A DECISION-SUPPORT TOOL AND DOES NOT PROVIDE MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT. OUTPUTS FROM THE SERVICE ARE AI-GENERATED AND MAY CONTAIN ERRORS. HEALTHCARE PROFESSIONALS MUST EXERCISE INDEPENDENT CLINICAL JUDGMENT AND VERIFY ALL INFORMATION BEFORE ACTING ON IT.

9.2 As-Is Service

THE SERVICE IS PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT.

10. Limitation of Liability

TO THE MAXIMUM EXTENT PERMITTED BY LAW, NANOSENSE SHALL NOT BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING BUT NOT LIMITED TO LOSS OF PROFITS, DATA, OR GOODWILL, ARISING OUT OF OR RELATED TO YOUR USE OF THE SERVICE. OUR TOTAL LIABILITY FOR ANY CLAIM ARISING UNDER THESE TERMS SHALL NOT EXCEED THE AMOUNT YOU PAID US IN THE TWELVE (12) MONTHS PRECEDING THE CLAIM.

11. Indemnification

You agree to indemnify and hold harmless NanoSense from any claims, damages, or expenses arising from: (a) your use of the Service in violation of these Terms; (b) your transmission of PHI without a signed BAA; (c) your failure to de-identify patient data; or (d) your end users' reliance on Service outputs without appropriate clinical oversight.

12. Termination

12.1 By You

You may terminate your account at any time by contacting us. Prepaid subscription fees are non-refundable for partial months.

12.2 By Us

We may suspend or terminate your access if you violate these Terms, fail to pay invoices, or if continued provision of the Service would violate applicable law. We will provide reasonable notice (except in cases of security breaches or legal requirements) and a 30-day data export window before permanent account deletion.

12.3 Effect of Termination

Upon termination, your API keys are revoked and access ceases immediately. Data retention and disposal follows our Data Retention Policy. Sections 7 (Data), 9 (Disclaimers), 10 (Liability), and 11 (Indemnification) survive termination.

13. Partner Integrations

If you access the Service through a partner application (e.g., Tamartaw), your use is also subject to the partner's terms of service. We are not responsible for the partner's application, data practices, or user experience. Partners access the Service under separate Partner Service Agreements.

14. Modifications to Terms

We may update these Terms from time to time. We will notify you of material changes at least 30 days before they take effect by posting the updated Terms and notifying you via email. Continued use of the Service after the effective date constitutes acceptance of the updated Terms.

15. Governing Law

These Terms are governed by the laws of the State of Delaware, without regard to conflict of law principles. Any disputes shall be resolved in the state or federal courts located in Delaware. Notwithstanding the foregoing, either party may seek injunctive relief in any court of competent jurisdiction.

16. Contact

For questions about these Terms, contact us at:

NanoSense

Email: legal@nanosense.net

General: hello@nanosense.net

Website: nanosense.net